Share this PR

Press Contact

Robson

SRA

Credence Research

105 N 1st ST #429, SAN JOSE, CA 95103, United States

8003618290

Contact Email

Social Media

Peptic Ulcer Drugs Market Record overwhelming hike in Revenues by 2025: Credence Research

PressReleasePing - September 18, 2017 -According to the latest market report published by Credence Research, Inc. “Peptic Ulcer Drugs Market- Growth, Future Prospects and Competitive Analysis, 2017 - 2025” the global Peptic ulcer drugs market was valued at US$ 4.63 Bn in 2016, and is expected to reach US$ 5.92 Bn by 2025, expanding at a CAGR of 2.8% from 2017 to 2025. Market Insights A peptic ulcer is forms of painful sores that develops on the mucosal lining of the stomach, small intestine or lower esophagus, mainly caused by Helicobacter pylori infection and long-term use of aspirin and certain other painkillers. For the purpose of study peptic ulcer drugs market is segmented on the basis of drug class such as antibiotics, proton pump inhibitors (PPIs), H2 receptor antagonists, gastric mucosal protective drugs, antacids and prostaglandin agonists. It is observed that currently, PPIs is major revenue generating segment because these drugs are recommended as a first line treatment for treatment of peptic ulcers caused by H. pylori bacterial infection and NSAIDs, due to its ability to reduce acid secretion. Request Sample: http://www.credenceresearch.com/sample-request/58606 Browse the full report Peptic Ulcer Drugs Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/peptic-ulcer-drugs-market It is studied that, in the base year 2016, North America dominated the peptic ulcer drugs market in terms of revenue and it is anticipated that it will show steady growth during forecast period. According to Centers for Disease Control and Prevention (CDC) peptic ulcer affects more than 6 million population in the United States annually. Factors such as large number of affected population, higher cost of treatment medication, improved diagnostic technique and upsurge in funding by the government agencies in healthcare system are driving the market growth in North America. On the other hand, Asia Pacific will show highest growth rate during forecast period due to changing lifestyle, higher number of affected population, increasing rate of smoking and rising healthcare awareness would expected to drive growth of peptic ulcers drugs market globally. Market Competition Assessment: The peptic ulcer drugs market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Abbott Laboratories, AstraZeneca plc, Cadila Healthcare Ltd, Daewoong Pharmaceuticals, Eisai Co. Ltd, PharmaKing Co. Ltd, Taiho Pharmaceutical (A Otsuka Holdings), Takeda Pharmaceutical, Yuhan Corporation and other. Key Market Movements: - Factors such as increase in number of target population, improved diagnostic techniques, easy availability of treatment medication, and preferable use of peptic ulcer medication over surgery and over use of painkiller medications are driving the growth of peptic ulcer drugs market globally. - Furthermore change in lifestyle such as stress, diet, increase in rate of smocking would assist growth of peptic ulcer drugs market. - However, wide availability of generic medication, poor patient compliance to medication in some countries and adverse effects associated with the use of medication which would negatively impacting market growth of peptic ulcer drugs. Table of Content: Chapter 1 Preface 1.1 Report Description 1.1.1 Purpose of the Report 1.1.2 Target Audience 1.1.3 USP and Key Offerings 1.2 Research Scope 1.3 Research Methodology 1.3.1 Phase I – Secondary Research 1.3.2 Phase II – Primary Research 1.3.3 Phase III – Expert Panel Review 1.3.4 Assumptions Chapter 2 Executive Summary 2.1 Global Peptic Ulcer Drugs Market Snapshot 2.2 Global Peptic Ulcer Drugs Market, Drug Class 2.3 Global Peptic Ulcer Drugs Market Share, by Geography, 2016 (Value %) Chapter 3 Peptic Ulcer Drugs Market Analysis 3.1 Global Peptic Ulcer Drugs Market Overview 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.2 Challenges 3.2.3 Opportunities 3.3 Pipeline Analysis in Peptic Ulcer Drugs Market 3.4 Global Epidemiology Data for Peptic Ulcer 3.5 Attractive Investment Proposition 3.6 Competitive Landscape of Key Players in Peptic Ulcer Drugs Market Chapter 4 Global Peptic Ulcer Drugs Market, by Drug Class 4.1 Overview 4.2 Top 3 Countries 4.3 Antibiotics 4.4 Proton Pump Inhibitors (PPIs) 4.5 H2 Receptor Antagonists 4.6 Gastric Mucosal Protective Drugs 4.7 Antacids 4.8 Prostaglandin Agonists…. Browse the full report Peptic Ulcer Drugs Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/peptic-ulcer-drugs-market Blog: • http://techtopworld.com/ • http://technorati.com/peptic-ulcer-drugs-market-size-market-share-trends-and-forecast-2017/ About: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task. Media Contact Name: Chris Smith Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US E-mail: sales@credenceresearch.com Ph: 1-800-361-8290 Web: http://www.credenceresearch.com


Creative Commons License

This press release is licensed under a Creative Commons Attribution 3.0 Unported License.